Suchergebnisse - "Kim, Arthur Y"

PubPharm (10)

1

Patient-centred models of hepatitis C treatment for people who inject drugs : a multicentre, pragmatic randomised trial

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Litwin, A. | Lum, P. | Taylor, L. | +28

CommentIn: Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1066-1068. - PMID 36370732

2

Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection

enthalten in: Journal of hepatology | 2021

von Matthews, G. | Bhagani, S. | Van der Valk, M. | +67

3

Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections : Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2019

von Naggie, S. | Fierer, D. | Hughes, M. | +41

4

Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate

enthalten in: The Journal of antimicrobial chemotherapy | 2018

von MacBrayne, C. | Marks, K. | Fierer, D. | +11

5

Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2017

von Sise, M. | Backman, E. | Ortiz, G. | +10

CommentIn: Clin J Am Soc Nephrol. 2017 Oct 6;12 (10 ):1563-1565. - PMID 28882856

6

Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1 : An Open-Label, Phase 3 Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2017

von Wyles, D. | Bräu, N. | Kottilil, S. | +16

7

Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents

enthalten in: Hepatology (Baltimore, Md.) | 2016

von Sise, M. | Bloom, A. | Wisocky, J. | +10

8

The safety and efficacy of ledipasvir/sofosbuvir for the treatment of a nosocomial outbreak of HCV in patients with significant cardiovascular disease

enthalten in: Antiviral therapy | 2016

von Simon, T. | Kim, A. | Stamm, L. | +9

9

The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection

enthalten in: Annals of internal medicine | 2015

von Linas, B. | Barter, D. | Morgan, J. | +9

CommentIn: Ann Intern Med. 2015 May 5;162(9):660-1. - PMID 25820765

10

PHOTON-2 : hope for patients with HIV and HCV co-infection?

enthalten in: Lancet (London, England) | 2015

von Naggie, S. | Kim, A.

CommentOn: Lancet. 2015 Mar 21;385(9973):1098-106. - PMID 25659285

1
[1]